Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated

Assessing the Severity of Your Condition

At a Glance

Ulnar neuropathy severity is assessed using both the physical examination and nerve tests. McGowan grades describe weakness and muscle wasting, while Padua and Zeidman grades describe electrical nerve damage; the results may differ and do not alone determine treatment.

To help you and your doctor decide on the best path forward, your condition is often “graded” using specific scales. These grades aren’t just numbers; they act as a guide that describes how much the nerve is struggling, though they supplement rather than replace your doctor’s clinical judgment [1][2].

The Clinical Map: The Modified McGowan Scale

One common system doctors use to describe your physical symptoms is the modified McGowan classification. This scale focuses on what you feel and what the doctor sees during an exam [3][4].

  • Grade I (Mild): You have “pins and needles” or numbness in your ring and pinky fingers, but your hand strength is normal [5]. (Note that a Grade I nerve can still have physiological damage.)
  • Grade IIA (Intermediate): You have numbness and objective weakness, meaning the doctor can measure a slight loss of strength in your hand muscles, even if you haven’t noticed it yet [4].
  • Grade IIB (Moderate): In addition to weakness, the doctor begins to see atrophy—the muscles in your hand are starting to look thinner or “sunken” because they aren’t getting enough nerve signals [6][4].
  • Grade III (Severe): There is significant muscle wasting and weakness. You may have difficulty using your hand for daily tasks, and your fingers may naturally curl into a “claw” shape [7][6].

The Electrical Map: Padua and Zeidman

While the clinical scale describes how you function, other scales like Padua and Zeidman describe what the electricity inside your nerve is doing [8]. These are based entirely on your nerve conduction study (NCS) and electromyography (EMG) results.

These scales categorize the nerve’s health into tiers (such as Mild, Moderate, or Severe) based on how slow the signals are moving or whether some signals are being blocked entirely [9][10]. To put it simply, they measure two concepts: conduction slowing or block (often early disease, where the nerve’s insulation is squeezed) and axonal loss (more advanced disease, where the nerve fibers themselves are damaged). It is important to know that these electrical grades do not always match your symptoms. For example, you might have significant pain, even if the test shows your nerve signals are moving at a relatively normal speed [11][8].

Why the Grade Matters for Your Care

Grading helps your medical team move from diagnosis to a plan of action. While every person is different and no grade alone dictates treatment, the grade often influences the starting point for discussion:

  1. Grade I: Doctors often start with conservative management, such as bracing or changing daily habits, to see if the nerve can recover [12][13].
  2. Grade II: When weakness or muscle thinning begins, the conversation often shifts toward whether specialist review or surgery is needed to “decompress” the nerve [14][15].
  3. Grade III: In severe cases where the nerve is under extreme distress, surgery is frequently the primary recommendation to prevent further muscle loss, although recovery at this stage may take longer and be less complete than in milder cases [6][16].

Understanding the “Mismatch”

It is common to experience severe pain and tingling, but have an electrical test that shows only mild slowing. This happens because tests can be less sensitive to the early stages of irritation or inflammation that cause pain [17][11]. Conversely, a severe electrodiagnostic abnormality with few symptoms may reflect chronic sensory loss, an asymptomatic abnormality, or technical factors [18]. This is why your doctor will look at the “Clinical Map” and the “Electrical Map” together, along with your physical examination, to get the full picture [8][13].

Common questions in this guide

What does a McGowan grade mean for ulnar neuropathy?
The modified McGowan scale grades ulnar neuropathy using symptoms and physical findings. Grade I usually means numbness or tingling without measurable weakness, grade IIA includes weakness a clinician can measure, grade IIB includes muscle wasting, and grade III indicates marked weakness and wasting. The grade supports but does not replace your doctor's overall assessment.
How are Padua and Zeidman grades different from McGowan grades?
Padua and Zeidman classifications are based on nerve conduction studies and electromyography, so they measure how electrical signals travel through the nerve. The McGowan scale is based mainly on symptoms and physical examination. The grades may not match because symptoms and electrical nerve changes can develop at different rates.
What is the difference between conduction slowing and axonal loss?
Conduction slowing or a conduction block means nerve signals are moving slowly or being interrupted, often because pressure affects the nerve's insulation. Axonal loss means the nerve fibers themselves are damaged and usually represents more advanced nerve injury. Clinicians use these findings with your examination to discuss treatment and recovery.
Does a severe ulnar neuropathy grade mean I need surgery?
A severe clinical grade often leads to discussion of surgical decompression, especially when there is substantial weakness or muscle wasting. However, no grade alone determines treatment; your symptoms, examination, test results, cause, and overall health also matter. Recovery can be slower and less complete when nerve damage is advanced.
Why can my EMG look mild when my ulnar neuropathy pain is severe?
Pain and tingling can occur early, when nerve conduction tests show only mild slowing or are less sensitive to irritation and inflammation. The reverse can also happen: an abnormal test with few symptoms may reflect long-standing sensory loss, a symptom-free abnormality, or technical factors. Doctors compare the test with your symptoms and physical examination rather than relying on one result.

Get notified when new evidence is published on ulnar neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Reliability and validity of the modified McGowan grade in patients with cubital tunnel syndrome.

    Choi SW, Bae JY, Shin YH, et al.

    Archives of orthopaedic and trauma surgery 2022; (142(7)):1697-1703 doi:10.1007/s00402-022-04367-8.

    PMID: 35107635
  2. 2

    Patient Characteristics in Ulnar Nerve Compression at the Elbow at a Tertiary Referral Hospital and Predictive Factors for Outcomes of Simple Decompression versus Subcutaneous Transposition of the Ulnar Nerve.

    Giöstad A, Nyman E

    BioMed research international 2019; (2019()):5302462 doi:10.1155/2019/5302462.

    PMID: 31950042
  3. 3

    Cubital Tunnel Syndrome: Does a Consensus Exist for Diagnosis?

    Collins DW, Rehak D, Dawes A, et al.

    The Journal of hand surgery 2025; (50(2)):230.e1-230.e7 doi:10.1016/j.jhsa.2023.05.014.

    PMID: 37422755
  4. 4

    Relationship between Clinical Severity and Cross-sectional Area of Ultrasonographic Examinations in Ulnar Neuropathy at the Elbow.

    Kurihara Y, Hanayama K, Furukawa T, et al.

    Progress in rehabilitation medicine 2023; (8()):20230025 doi:10.2490/prm.20230025.

    PMID: 37621410
  5. 5

    Relations between sensory symptoms, touch sensation, and sensory neurography in the assessment of the ulnar neuropathy at the elbow.

    Ginanneschi F, Aretini A, Mondelli M

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2019; (130(2)):199-206 doi:10.1016/j.clinph.2018.11.020.

    PMID: 30580242
  6. 6

    From deficit to recovery: postoperative neurological improvements in patients with severe cubital tunnel syndrome.

    Uerschels AK, Chihi M, Olbrich A, et al.

    Brain & spine 2026; (6()):106033 doi:10.1016/j.bas.2026.106033.

    PMID: 42016456
  7. 7

    Combined Outerbridge-Kashiwagi Procedure and Supercharged Anterior Interosseous Nerve Transfer for Elbow Arthritis With Ulnar Neuropathy: Refinements in Surgical Aspects of the Combined Approach.

    Cha SM, Lee SH, Xu J, et al.

    Annals of plastic surgery 2026; (96(1)):39-47 doi:10.1097/SAP.0000000000004567.

    PMID: 41417705
  8. 8

    Ulnar Neuropathy at the Elbow: Evaluation of Discriminatory Performance of Multitiered Electrodiagnostic-Based Severity Classifications.

    Savage NJ, McKell JS

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2026; doi:10.1097/WNP.0000000000001286.

    PMID: 42519962
  9. 9

    An electrodiagnostic grading system for ulnar neuropathy at the elbow.

    Zeidman LA, Pandey DK

    Muscle & nerve 2020; (62(6)):717-721 doi:10.1002/mus.27051.

    PMID: 32856738
  10. 10

    Preoperative Electrophysiology in Patients With Ulnar Nerve Entrapment at the Elbow-Prediction of Surgical Outcome and Influence of Age, Sex and Diabetes.

    Anker I, Nyman E, Zimmerman M, et al.

    Frontiers in clinical diabetes and healthcare 2022; (3()):756022 doi:10.3389/fcdhc.2022.756022.

    PMID: 36992728
  11. 11

    Ulnar nerve entrapment neuropathy at the elbow: relationship between the electrophysiological findings and neuropathic pain.

    Halac G, Topaloglu P, Demir S, et al.

    Journal of physical therapy science 2015; (27(7)):2213-6 doi:10.1589/jpts.27.2213.

    PMID: 26311956
  12. 12

    Conservative treatment of cubital tunnel syndrome: A systematic review.

    Kooner S, Cinats D, Kwong C, et al.

    Orthopedic reviews 2019; (11(2)):7955 doi:10.4081/or.2019.7955.

    PMID: 31281598
  13. 13

    Ulnar neuropathy.

    Hannaford A, Simon NG

    Handbook of clinical neurology 2024; (201()):103-126 doi:10.1016/B978-0-323-90108-6.00006-5.

    PMID: 38697734
  14. 14

    Surgical Decision Making for Mild-to-Moderate Cubital Tunnel Syndrome.

    Onyekwere IC, Victoria C, Kim A, et al.

    Journal of hand surgery global online 2024; (6(3)):390-394 doi:10.1016/j.jhsg.2024.02.011.

    PMID: 38817757
  15. 15

    Ulnar neuropathy at the elbow: from diagnosis to rehabilitation.

    Donati D, Morselli M, Ricci V, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(11)).

    PMID: 42897360
  16. 16

    Predictors of surgical outcomes for severe cubital tunnel syndrome: a review of 146 patients.

    Tong J, Dong Z, Xu B, et al.

    Acta neurochirurgica 2018; (160(3)):645-650 doi:10.1007/s00701-017-3420-9.

    PMID: 29214401
  17. 17

    Proposal for an efficient, minimal electrodiagnostic protocol for confirmation of clinically diagnosed ulnar nerve entrapment neuropathy at the elbow.

    Kurver A, Meulstee J, Bartels RHMA, Verhagen WIM

    Frontiers in neurology 2025; (16()):1664216 doi:10.3389/fneur.2025.1664216.

    PMID: 41132883
  18. 18

    Comparison of electrodiagnostic findings in acute traumatic versus chronic non-traumatic ulnar neuropathy at the elbow.

    Robinson LR, Broadhurst P, Wasserman A

    Muscle & nerve 2024; (69(2)):218-221 doi:10.1002/mus.28008.

    PMID: 38009374

This page explains how clinicians assess ulnar neuropathy severity for educational purposes only. It does not replace medical advice; discuss your examination, test results, and treatment options with your healthcare professional.

Guide contents ulnar neuropathy
Research & Literature
03 Getting an Accurate Diagnosis 05 Managing Ulnar Neuropathy Without Surgery